英文名稱 |
中文名稱 |
CAS號 |
操作 |
Allisartan Isoproxil Impurity 14 |
氯沙坦甲醛 |
114798-36-6 |
詳細(xì)
|
Malaridine |
磷酸咯萘啶 |
74847-35-1 |
詳細(xì)
|
Upadacitinib Impurity 91(Hydrochloride) |
烏帕替尼雜質(zhì)91(鹽酸鹽) |
|
詳細(xì)
|
Mosapride Impurity 20(Dihydrochloride) |
莫沙比利雜質(zhì)20(雙鹽酸鹽) |
|
詳細(xì)
|
Metaraminol Bitartrate Impurity 56 |
Benzenemethanol, a-ethyl-3-hydroxy- |
55789-02-1 |
詳細(xì)
|
Entecavir Impurity 29 |
8-羥基恩替卡韋 |
2204369-23-1 |
詳細(xì)
|
FurosemideImpurity 14 |
|
|
詳細(xì)
|
Rocuronium Bromide Intermediate 1 |
(2b,3a,5a,16b,17b)-2-(4-嗎啉基)-16-(1-吡咯烷基)雄甾烷-3,17-二醇 |
119302-20-4 |
詳細(xì)
|
Bromhexine Impurity 15 |
溴己新雜質(zhì)15 |
|
詳細(xì)
|
Avatrombopag Impurity 29 |
阿伐曲泊帕雜質(zhì)20 |
959042-70-7 |
詳細(xì)
|
Haloperidol Impurity 23(Hydrochloride) |
氟哌啶醇雜質(zhì)23(鹽酸鹽) |
|
詳細(xì)
|
Mirabegron Enantiomer Impurity |
米拉貝隆雜質(zhì) |
1796931-48-0 |
詳細(xì)
|
Isavuconazole Impurity 21 |
艾沙康唑雜質(zhì)21 |
|
詳細(xì)
|
Mivacurium Chloride Impurity C |
美維松氯化物雜質(zhì)4 |
714192-43-5 |
詳細(xì)
|
Empagliflozin Impurity 117 |
恩格列凈雜質(zhì)117 |
1620758-30-6 |
詳細(xì)
|
Indobufen Impurity 12 |
Benzeneacetonitrile, 4-amino-α-ethyl- |
15494-55-0 |
詳細(xì)
|
Oseltamivir Impurity 49(Ditrifluoroacetate) |
奧司他韋雜質(zhì)49(雙三氟乙酸鹽) |
|
詳細(xì)
|
Upadacitinib Impurity 83 |
烏帕替尼雜質(zhì)83 |
|
詳細(xì)
|
Carbidopa EP Impurity F |
卡比多巴雜質(zhì)F |
1458640-32-8 |
詳細(xì)
|
Asparagine EP Impurity C |
天冬酰胺EP雜質(zhì)C |
98490-54-1 |
詳細(xì)
|
Peramivir Impurity 33 |
帕拉米韋雜質(zhì)33 |
2758048-78-9 |
詳細(xì)
|
Nebivolol Impurity 36 |
奈必洛爾雜質(zhì)36 |
1219915-01-1 |
詳細(xì)
|
Empagliflozin Impurity 127 |
恩格列凈雜質(zhì)127 |
|
詳細(xì)
|
Malaridine Impurity 11 (Trihydrochloride) |
// |
749260-32-0 |
詳細(xì)
|
Baloxavir Marboxil Impurity 3 |
7,8 -二氟- 6,11 -二氫-二苯并[ B,E ]噻吩并- 11 -醇 |
1985607-83-7 |
詳細(xì)
|
Upadacitinib Impurity 19 |
烏帕替尼N-2 |
2095311-51-4 |
詳細(xì)
|
Regadenoson Impurity 3 |
瑞加德松雜質(zhì)1 |
313348-29-7 |
詳細(xì)
|
FurosemideImpurity 10 |
|
|
詳細(xì)
|
Brivaracetam Impurity 58 |
布瓦西坦雜質(zhì)31 |
2096999-79-8 |
詳細(xì)
|
Atracurium Impurity 41 |
阿曲庫銨雜質(zhì)48 |
24948-17-2 |
詳細(xì)
|
Rosuvastatin Impurity 148 |
瑞舒伐他汀雜質(zhì)148 |
|
詳細(xì)
|
Metaraminol Bitartrate Impurity 63 |
吉培福林 |
18840-47-6 |
詳細(xì)
|
Malaridine Impurity 3 |
咯萘啶雜質(zhì)3 |
1422180-92-4 |
詳細(xì)
|
Baloxavir Sulfone |
巴洛沙韋砜 |
|
詳細(xì)
|
Vildagliptin Oxidation Impurity |
維格列汀氧化雜質(zhì) |
|
詳細(xì)
|
Mosapride Impurity 31(Sodium salt) |
莫沙比利雜質(zhì)31(鈉鹽) |
|
詳細(xì)
|
Baloxavir Marboxil Impurity 4 |
3-(芐氧基)-4-氧代-4H-吡喃-2-羧酸 |
119736-16-2 |
詳細(xì)
|
Ritonavir EP Impurity G |
利托那韋EP雜質(zhì)G |
2034136-66-6 |
詳細(xì)
|
Nicorandil Impurity 16 |
尼古拉地爾雜質(zhì)16 |
1157-74-0 |
詳細(xì)
|
Baloxavir Impurity 45 |
巴洛沙韋雜質(zhì)45 |
|
詳細(xì)
|
Nefopam Impurity 10 |
2-(1-羥基芐基)-N-(2-羥基乙基)-N-甲基芐胺 |
60725-36-2 |
詳細(xì)
|
Nicardipine Impurity 33 |
尼卡地平雜質(zhì)33 |
54527-90-1 |
詳細(xì)
|
Benflumetol Impurity 2 |
本芴醇雜質(zhì) |
2170653-95-7 |
詳細(xì)
|
Metaraminol bitartrate Impurity 36 |
重酒石酸間羥胺雜質(zhì)36 |
|
詳細(xì)
|
4-Hydroxymethyl Loratadine |
4-羥甲基氯雷他定 |
609806-40-8 |
詳細(xì)
|
Relugolix Impurity 96 |
瑞盧戈利雜質(zhì)8 |
2814571-33-8 |
詳細(xì)
|
Dobutamine Impurity 8(Hydrochloride) |
多巴酚丁胺雜質(zhì)8(鹽酸鹽) |
|
詳細(xì)
|
Urapidil Impurity 11(Dioxalate) |
烏拉地爾雜質(zhì)11(雙草酸鹽) |
|
詳細(xì)
|
Mometasone Furoate EP Impurity Q |
莫米松中間體(S14-2) |
83881-08-7 |
詳細(xì)
|
Avatrombopag Impurity 10 |
5,6-二氯煙酸 |
41667-95-2 |
詳細(xì)
|
Miglitol Isomer A |
米格利托雜質(zhì)2 |
1370331-33-1 |
詳細(xì)
|
Parecoxib Impurity 49 |
帕瑞昔布鈉雜質(zhì)40 |
1448355-87-0 |
詳細(xì)
|
Haloperidol Decanoate EP Impurity J |
SILFUYMQHCIFAV-UHFFFAOYSA-N |
1797983-18-6 |
詳細(xì)
|
Lasmiditan Impurity 4 |
拉米地坦雜質(zhì)4 |
517875-04-6 |
詳細(xì)
|
1,3-dihydroxypropan-2-yl 4-hydroxybenzoate |
1,3-dihydroxypropan-2-yl 4-hydroxybenzoate |
263552-76-7 |
詳細(xì)
|
Venetoclax Impurity 28 |
維萘妥拉雜質(zhì)3 |
2142574-09-0 |
詳細(xì)
|
Upadacitinib Impurity 3 |
烏帕替尼雜質(zhì)3 |
2304514-60-9 |
詳細(xì)
|
Bumetanide Photodegradable Impurity 15 |
布美他尼光降解雜質(zhì)15 |
|
詳細(xì)
|
Dobutamine Impurity 17(Hydrochloride) |
多巴酚丁胺雜質(zhì)17(鹽酸鹽) |
|
詳細(xì)
|
Glycopyrrolate Isomer Impurity |
利吡咯溴銨 |
58493-54-2 |
詳細(xì)
|
Haloperidol N-Oxide (Mixture of Isomers) |
氟哌啶醇N氧化物 |
148406-51-3 |
詳細(xì)
|
Nebivolol Impurity 34 |
(S)-6-氟-3,4-二氫-2H-1-苯并吡喃-2-羧酸 |
129101-36-6 |
詳細(xì)
|
Avatrombopag Impurity 6 |
4-(4-氯-2-噻吩基)-2-噻唑胺 |
570407-10-2 |
詳細(xì)
|
Prilocaine EP Impurity G(Hydrochloride) |
丙胺卡因雜質(zhì) |
1049712-77-7 |
詳細(xì)
|
Nebivolol Impurity 38 |
奈必洛爾雜質(zhì)38 |
1335103-90-6 |
詳細(xì)
|
Albuterol Impurity 37 |
沙丁胺醇雜質(zhì)37 |
|
詳細(xì)
|
Dapoxetine HCl |
鹽酸達(dá)泊西汀 |
129938-20-1 |
詳細(xì)
|
Oseltamivir Impurity 27(Dihydrochloride) |
奧司他韋雜質(zhì)27(雙鹽酸鹽) |
|
詳細(xì)
|
Rocuronium Bromide Impurity 34 |
羅庫溴銨起始原料A雜質(zhì)Ⅵ-B |
144209-33-6 |
詳細(xì)
|
Dopamine |
2-(3,4-二羥基苯基)乙胺 |
51-61-6 |
詳細(xì)
|
Avatrombopag (AKR-501) |
阿伐曲泊帕 |
570406-98-3 |
詳細(xì)
|
Pinaverium Bromide Impurity 9 |
匹維溴銨雜質(zhì) |
38284-47-8 |
詳細(xì)
|
Upadacitinib Impurity 17 |
芐基(3R,4S)-3-(N-(乙氧基羰基)-N-(5-甲苯磺?;?5H-吡咯并[2,3-b]吡嗪-2-基)甘氨?;?-4-乙基吡咯烷-1-羧酸酯 |
2050038-81-6 |
詳細(xì)
|
Pitavastatin Impurity 52 |
匹伐他汀雜質(zhì)52 |
|
詳細(xì)
|
Baloxavir Marboxil Impurity 20 |
巴洛沙韋中間體 |
2136287-65-3 |
詳細(xì)
|
Relugolix Impurity 49 |
瑞盧戈利雜質(zhì)43 |
6378-51-4 |
詳細(xì)
|
Ilaprazole Impurity 35 |
吡啶, 4-甲氧基-2,3-二甲基- (9CI) |
163593-69-9 |
詳細(xì)
|
Carbidopa EP Impurity H(Hydrochloride) |
卡比多巴EP雜質(zhì)H(鹽酸鹽) |
|
詳細(xì)
|
Olodaterol Impurity 29 |
奧達(dá)特羅雜質(zhì)29 |
|
詳細(xì)
|
Iguratimod Impurity 25 |
艾拉莫德雜質(zhì)25 |
|
詳細(xì)
|
Upadacitinib Impurity 81 |
烏帕替尼雜質(zhì)81 |
|
詳細(xì)
|
Carbazochrome Impurity 11 |
卡絡(luò)磺鈉雜質(zhì)6 |
130570-60-4 |
詳細(xì)
|
Rosuvastatin Impurity 166 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester |
1326303-05-2 |
詳細(xì)
|
Betamethasone EP Impurity B |
氯倍他索 |
25122-41-2 |
詳細(xì)
|
Nebivolol Impurity 39 |
奈必洛爾雜質(zhì)39 |
1219914-99-4 |
詳細(xì)
|
Nebivolol Impurity 35 |
奈必洛爾雜質(zhì)35 |
129050-25-5 |
詳細(xì)
|
Brivaracetam Impurity 62 |
布瓦西坦雜質(zhì)62 |
|
詳細(xì)
|
Morinidazole Impurity 17 |
嗎啉硝唑雜質(zhì)16 |
87008-47-7 |
詳細(xì)
|
Upadacitinib Impurity 1 |
(3S,4S)-3-(2-溴乙?;?-4-乙基吡咯烷-1-羧酸芐酯 |
2868258-96-0 |
詳細(xì)
|
Bumetanide Impurity 10 |
4-氯-3-硝基-5-磺酰胺基苯甲酸 |
22892-96-2 |
詳細(xì)
|
Agomelatine Impurity 18 |
阿戈美拉汀雜質(zhì)醇 |
32820-10-3 |
詳細(xì)
|
Tedizolid Impurity 53 |
N-(4-溴-2-氟苯基)氨基甲酸芐酯 |
1259078-16-4 |
詳細(xì)
|
Olodaterol Impurity 10 |
8-(2R)-環(huán)氧乙烷基-6-(芐氧基)-2H-1,4-苯并惡嗪-3(4H)-酮 |
869478-12-6 |
詳細(xì)
|
Upadacitinib Impurity 14 |
(3R,4S)-3-(2-溴乙?;?-4-乙基-1-吡咯烷羧酸芐酯 |
1428243-26-8 |
詳細(xì)
|
Baloxavir Marboxil Impurity 14 |
巴洛沙韋中間體 |
2136287-66-4 |
詳細(xì)
|
Amlodipine |
氨氯地平 |
88150-42-9 |
詳細(xì)
|
Atracurium Impurity 42 |
勞丹素(半日花素) |
1699-51-0 |
詳細(xì)
|
1,3-Dibromobutane |
1,3-二溴丁烷 |
107-80-2 |
詳細(xì)
|
Rosuvastatin Impurity 154 |
瑞舒伐他汀雜質(zhì)92 |
404958-68-5 |
詳細(xì)
|
Nafamostat Mesylate |
甲磺酸萘莫司他 |
82956-11-4 |
詳細(xì)
|